ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 669727 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 669727; 2) Community: the network communities that were significantly associated with the response to NSC 669727; 3) Molecule: the relationships between components within communities and NSC 669727; 4) MDR: the compounds that were significantly associated with the NSC 669727.

NSC Compound Enrichment Correlation
NSC 11240 Aizen Victoria Blue BOH 0.00640068043275779 -0.12770876
NSC 638436 Null 0.00640068043275779 0.51053355
NSC 653267 Null 0.00640068043275779 0.23212558
NSC 85235 10.alpha.H-Ambrosa-2,11(13)-dien-12-oic acid, 6.beta.-hydroxy-4-oxo-, .gamma.-lactone (8CI) 0.00648124190744027 -0.033319769
NSC 675774 Null 0.00671035899671664 0.30570964
NSC 736042 5-chloro-2[(E)-2-(4-nitrophenyl)vinyl]-1H-benzimidazole 0.00671035899671664 0.21976204
NSC 752879 3-(3-chloro-5-methoxyphenyl)-N-(2-(4-methylpiperazin-1-yl)ethyl)-4-(pyridin-4-yl)-1H-pyrazole-1-carboxamide 0.00705866970012639 -0.073355102
NSC 697192 Decanediamide, N,N'-bis[2-(2-hydroxy-1-naphthalenyl)- 5-(3,4-dihydroxyphenyl)methylene]-4-oxo- 3-thiazolidinyl]- 0.00705866970012644 0.43714718
NSC 709237 Camptothecin Derivative 0.00705866970012644 0.59497632
NSC 80103 2,3-Butanediol, 1,4-bis(2-methyl-1-aziridinyl)- (8CI) 0.00705866970012644 0.66659179
Total:43  Current:5    [First] [Prev] [Next] [Last]